Clinical Trials Directory

Trials / Completed

CompletedNCT02837744

Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure

Safety and Efficacy of Axiostat® Hemostatic Dressing on Radial Access After Percutaneous Procedure

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Axio Biosolutions Pvt. Ltd. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To evaluate Safety and Efficacy of Axiostat® hemostatic dressing in terms of time to achieve hemostasis, post application complication and comfort levels of patients.

Detailed description

To evaluate Safety and Efficacy of Axiostat® hemostatic dressing in terms of time to achieve hemostasis, post application complication and comfort levels of patients who have undergone radial intervention.

Conditions

Interventions

TypeNameDescription
DEVICEAxiostat®Axiostat Chitosan Hemostatic dressing belongs to an advanced class of wound dressing that stops bleeding within few minutes of application by providing an active mechanical barrier.

Timeline

Start date
2016-09-01
Primary completion
2017-11-01
Completion
2017-11-01
First posted
2016-07-20
Last updated
2021-03-11
Results posted
2021-03-11

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02837744. Inclusion in this directory is not an endorsement.

Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure (NCT02837744) · Clinical Trials Directory